Nobel Laureate Dr. Roger Kornberg discusses impact of biosensor technology on Antimicrobial Resistance.

LONDON, UK – July 12, 2016 – In a recent interview with HealthPad, a UK-based medical information dissemination and resource company, Nobel Laureate Dr. Roger Kornberg discussed the concern in the rise of illness and death due to Antimicrobial Resistance and how new biosensor technology can potentially be a step-change in eradicating this threat.



The following is the full article from HealthPad. Click here to view on Healthpad website.

Slowing the steep rise of antimicrobial resistance

  • Currently 700,000 people die each year from Antimicrobial Resistance (AMR) and this could rise to 10 milion by 2050
  • AMR could make routine surgeries and childbirth as dangerous and lethal as in the pre-antibiotic era killing millions and costing trillions worldwide
  • Doctors inappropriately prescribing antibiotics for minor aliments shorten the useful life of antibiotics threatening modern medicine as there is an antibiotic pipeline deficiency
  • 90% of GPs feel pressured by patients to prescribe antibiotics
  • 70% of GPs are unsure whether sore throat and respiratory infections are viral or bacterial resulting in 50% of sore throats receiving antibiotics
  • Clinical diagnosis leads to 50% of patients with a sore throat being prescribed antibiotics without having Group A Streptococcal infection
  • 30% of patients with pharyngitis will not be treated but will be infected with Group A Streptococci
  • 24% of doctors say they lack easy-to-use diagnostic tools
  • 10m prescriptions for antibiotics are handed out in England each year to patients who do not need them
  • A Nobel Laureate has developed a new technology to provide rapid, accurate, cost-effective diagnosis of bacterial sore throat resulting in informed prescribing and reducing unnecessary antibiotic usage

Should we listen when a professor of medicine and a Nobel Laureate says that the technology already exists to develop a cheap hand held device, which can rapidly and accurately diagnose a bacterial sore throat?

Without such a device to determine whether minor ailments require antibiotics, doctors will continue to prescribe them, and thereby contribute to the steep rise in Antimicrobial Resistance (AMR). In 2016 the National Institute for Health and Care Excellence (NICE), the UK government’s NHS watchdog, reported that as many as 10m prescriptions for antibiotics are handed out in England every year to patients who do not need them. According to a 2016 report on AMR, by 2050 a staggering, “10m people will die from AMR each year . . . . The world needs rapid diagnostics to improve our use of antibiotics,” says the report.

next: Sore Throat Infections >>

Sensor-Kinesis – Advanced Biosensor Technology: Patent Filing Press Release

Sensor-Kinesis Reveals New Carbon Nanotube BioFET for Analysis of Biomarkers

LOS ANGELES – May 12, 2015 – Sensor-Kinesis Corporation (SKC) announced the filing of a U.S. patent application entitled “Carbon Nanotube BioFET with a Local Amplifier in a System Array for Analysis of Biomarkers and Method of Analysis of Same”. The announcement was made in conjunction with SKC’s parent company, Pharmaco-Kinesis Corporation. Read more

Sensor-Kinesis – Advanced Biosensor Technology: SBIR Grant Press Release

Department of Defense Awards Grant to Develop Biosensor for Early Detection of Acute Organ Injury

LOS ANGELES, CALIFORNIA, May 31, 2014 – Sensor-Kinesis Corporation (SKC) announced that its parent company Pharmaco-Kinesis Corporation (PKC) has been awarded a grant by the U.S. Department of Defense (DoD) for development of its “Carbon Nanotube Based Biosensor for Organ Injury Detection”. SKC’s biosensor technology was competitively selected for the Phase I grant award, totaling $150,000, under the Small Business Innovation Research (SBIR) program of the DoD Defense Health Program (DHP). Read More

Frost & Sullivan Acknowledges That SKC’s Biosensors Are Expected To Become The New Industry Standard In Pathogen Testing

MOUNTAIN VIEW, CALIFORNIA, February 13, 2013 – Based on its recent analysis of the global biosensors market, Frost & Sullivan recognized Sensor-Kinesis’ (SKC) parent company  Pharmaco-Kinesis Corporation (PKC) with the 2013 Global Frost & Sullivan Award for New Product Innovation. The company has set a new standard in the biosensors market with its innovative, highly sensitive biosensor. Read more